🔴 Firefly Neuroscience is trading 5.4% down today; catalyst remains uncertain

Firefly Neuroscience is trading 5.4% down at $0.95, with no clearly identifiable company-specific announcement explaining the September 16, 2026 decline.

• Recent coverage focuses on the September 8 termination of CFO Paul Krzywicki, effective September 24, and Jessica Paz’s appointment as chief accounting officer; the event predates the move and is not directly linked.
• Broader markets are modestly higher as investors await the Federal Reserve’s policy decision, so the stock is not clearly tracking overall sentiment.
• The catalyst remains uncertain and may warrant rechecking for delayed filings or news.